The Association Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease Outcomes
- PMID: 30988909
- PMCID: PMC6385911
- DOI: 10.1002/cld.721
The Association Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease Outcomes
Figures
Similar articles
-
Nonalcoholic fatty liver disease and cardiovascular disease phenotypes.SAGE Open Med. 2020 Jun 20;8:2050312120933804. doi: 10.1177/2050312120933804. eCollection 2020. SAGE Open Med. 2020. PMID: 32612827 Free PMC article. Review.
-
Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment (II). The treatment of nonalcoholic fatty liver disease.Clin Investig Arterioscler. 2017 Jul-Aug;29(4):185-200. doi: 10.1016/j.arteri.2016.06.002. Epub 2016 Sep 28. Clin Investig Arterioscler. 2017. PMID: 27692632 Review. English, Spanish.
-
Ideal Cardiovascular Health Is Inversely Associated with Nonalcoholic Fatty Liver Disease: A Prospective Analysis.Am J Med. 2018 Dec;131(12):1515.e1-1515.e10. doi: 10.1016/j.amjmed.2018.07.011. Epub 2018 Aug 1. Am J Med. 2018. PMID: 30075104
-
Chronic kidney disease is independently associated with increased mortality in patients with nonalcoholic fatty liver disease.Liver Int. 2019 Feb;39(2):342-352. doi: 10.1111/liv.13992. Epub 2018 Dec 4. Liver Int. 2019. PMID: 30347513
-
[Relationship between ideal cardiovascular behaviors/factors and the prevalence of nonalcoholic fatty liver disease].Zhonghua Liu Xing Bing Xue Za Zhi. 2015 Jan;36(1):40-4. Zhonghua Liu Xing Bing Xue Za Zhi. 2015. PMID: 25876863 Chinese.
Cited by
-
Triglyceride to high-density lipoprotein cholesterol ratio is an independent predictor of liver fibrosis among pediatrics non-alcoholic fatty liver disease.Front Endocrinol (Lausanne). 2022 Dec 16;13:1071350. doi: 10.3389/fendo.2022.1071350. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36589844 Free PMC article.
-
Association between the LRP5 rs556442 gene polymorphism and the risks of NAFLD and CHD in a Chinese Han population.BMC Gastroenterol. 2022 Jun 22;22(1):305. doi: 10.1186/s12876-022-02385-9. BMC Gastroenterol. 2022. PMID: 35733105 Free PMC article.
-
Evaluation and management of extrahepatic manifestations of nonalcoholic fatty liver disease.Clin Mol Hepatol. 2021 Apr;27(2):221-235. doi: 10.3350/cmh.2020.0239. Epub 2020 Dec 3. Clin Mol Hepatol. 2021. PMID: 33317243 Free PMC article. Review.
-
Lipotoxicity as the Leading Cause of Non-Alcoholic Steatohepatitis.Int J Mol Sci. 2022 May 5;23(9):5146. doi: 10.3390/ijms23095146. Int J Mol Sci. 2022. PMID: 35563534 Free PMC article. Review.
-
Relationship between Adipokines and Cardiovascular Ultrasound Parameters in Metabolic-Dysfunction-Associated Fatty Liver Disease.J Clin Med. 2021 Nov 7;10(21):5194. doi: 10.3390/jcm10215194. J Clin Med. 2021. PMID: 34768714 Free PMC article.
References
-
- Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, et al. The natural history of nonalcoholic fatty liver disease: A population‐based cohort study. Gastroenterology 2005;129:113‐121. - PubMed
-
- Ekstedt M, Franzén LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, et al. Long‐term follow‐up of patients with NAFLD and elevated liver enzymes. Hepatology 2006;44:865‐873. - PubMed
-
- Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413‐1419. - PubMed
-
- Targher G, Day CP, Bonora B. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010;363:1341‐1350. - PubMed
-
- Wong VW‐S, Wong GL, Yeung JC, Fung CY, Chan JK, Chang ZH, et al. Long‐term clinical outcomes after fatty liver screening in patients undergoing coronary angiogram: A prospective cohort study. Hepatology 2016;63:754‐763. - PubMed
Publication types
LinkOut - more resources
Full Text Sources